3 citations
,
September 2023 in “Advanced science” Researchers demonstrated that a new vaccine platform using antigen-loaded hydrogels enhanced humoral immune responses in mice, producing stronger antigen-specific antibody levels compared to the conventional adjuvant Alum, and offering promising protective capabilities against influenza virus.
3 citations
,
March 2021 in “Indian Journal of Rheumatology” This study presents a case where telemedicine allowed for early detection of a dermatomyositis flare during the COVID-19 pandemic using simple patient-reported measures, despite challenges in remote assessment.
This review highlights the potential of microneedles as a pediatric-friendly method for delivering proteins, vaccines, and diagnostics transdermally, noting their ability to penetrate the skin's barrier and suggesting future applications in other parts of the body.
June 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” This study found that a novel bioengineered microneedle patch successfully delivered minoxidil to induce hair growth in a mouse model, suggesting a promising approach to improve treatment for androgenetic alopecia.
June 2021 in “SWU eJournals System (Srinakharinwirot University)” The study found that cyproterone acetate could be released over 15 days using coconut oil mixed with certain wax inhibitors, though further safety studies are needed.
April 2005 in “Clinics in Plastic Surgery” This review discusses the use of lasers in plastic surgery for various conditions and reports no new clinical results; the authors note effective treatment options for patients across different ethnic backgrounds.
September 2022 in “International Journal of Trichology” In this study, microneedling and intralesional corticosteroid injections in patients with alopecia areata showed similar hair regrowth effectiveness, with microneedling resulting in more uniform but less dense regrowth and fewer side effects.
1 citations
,
July 2023 in “Journal of the American Academy of Dermatology” This review reports that pressure-induced alopecias, occurring from ischemic pressure, are often reversible without treatment if diagnosed promptly, but prognosis varies with severity and treatment timing.
22 citations
,
November 2002 in “Clinical journal of oncology nursing” This article discusses arsenic trioxide as a treatment for refractory or relapsed acute promyelocytic leukemia, noting its effectiveness and manageable side effects.
21 citations
,
September 2019 in “International Journal of Nanomedicine” RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.
20 citations
,
January 2000 in “Dermatologic Clinics” This article discusses recent advancements in treatments for psoriasis, including new drug approvals and innovative therapeutic approaches, but reports no new clinical results.
11 citations
,
August 2024 in “Advanced Healthcare Materials” In this study, a peptide hydrogel scaffold loaded with umbilical cord-derived mesenchymal stem cells was used to repair damaged endometrium in rats, significantly improving fertility and live birth rates by restoring endometrial thickness and promoting angiogenesis.
6 citations
,
February 2023 in “Biomaterials Research” This review explores the different types of hydrogels used to repair diabetic ulcers, the mechanisms involved, and the limitations in developing these technologies for clinical use, but it reports no new clinical results.
3 citations
,
January 2015 in “Social Science Research Network” This study discusses the role of physicians and pharmaceutical companies as entrepreneurial actors in off-label drug use, arguing they may advance patient care more quickly than regulatory agencies.
1 citations
,
October 2023 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” This review examines the psychological impacts of androgenic alopecia on women and evaluates existing treatment methods, highlighting the need for more effective and accessible therapeutic approaches.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This single patient case report observed that Vidarikandadi Kala Basti, an Ayurvedic Panchakarma procedure, was linked to modest improvements in Vitamin B12 levels and clinical symptoms, but larger studies are needed to determine its potential role in managing Vitamin B12 deficiency.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this case report, a 22-year-old male with Vitamin B12 deficiency showed improved clinical symptoms and a modest rise in Vitamin B12 levels after undergoing classical Panchakarma therapy, though the authors emphasize that causality remains undetermined and further research is necessary.
June 2026 in “International Journal Of Ayurvedic And Herbal Medicine” This case report described the use of Vidarikandadi Kala Basti, a Panchakarma procedure, which was associated with improved symptoms and a modest Vitamin B12 increase in a patient with deficiency; however, the authors noted that causality cannot be established, and further controlled studies are needed.
June 2026 in “Annals of Medicine and Surgery” This study highlights the approval of orforglipron under the FDA's National Priority Voucher program, emphasizing its significance as a convenient oral treatment option with beneficial effects on glycemic and lipid profiles for diabetes and obesity management.
January 2026 in “Journal of Cosmetic Dermatology” This study reviewed evidence suggesting that the loss of dermal white adipose tissue (dWAT) during menopause may be linked to decreased estrogen levels, potentially affecting skin health, and discussed non-hormonal treatments, like magnolol, that might help restore dWAT and improve menopausal skin changes.
December 2025 in “Actas Dermo-Sifiliográficas” This consensus from 22 Spanish dermatologists recommends using a multimodal therapy starting with oral dutasteride, combined with topical and/or intralesional agents, and adding hydroxychloroquine if inflammation persists, to manage frontal fibrosing alopecia due to its irreversible hair loss and lack of specific approved treatments.
September 2025 in “International Journal of Innovative Technologies in Social Science” This study reviewed aesthetic gynecology procedures, reporting that most are safe, well tolerated, and yield high patient satisfaction, particularly for postmenopausal and postpartum women. However, the study highlights the need for standardized protocols and long-term data.
This study reviews the medicinal uses of Catharanthus roseus, highlighting its production of valuable anticancer alkaloids like vincristine and vinblastine, and its applications in treating diabetes, hypertension, and infections, but also notes potential side effects such as nausea and myelosuppression, especially at high doses.
September 2024 in “Annals of Medicine and Surgery” In this review, the authors highlight the FDA approval of Ritlecitinib, the first oral treatment specifically for moderate to severe alopecia areata in patients aged 12 and older, marking a significant advancement in managing this condition.
September 2024 in “Journal of Cosmetic Dermatology” Cold gel compresses are the best for pain relief during scalp microneedling.
July 2024 in “JPRAS Open” This research highlights that lip feminization, an essential aspect of facial feminization surgeries for transgender women, lacks dedicated studies, underscoring a significant gap in understanding and optimizing this procedure for gender expression.
April 2024 in “International Journal of Research Publication and Reviews” This source highlights that alopecia areata is a complex autoimmune disorder leading to patchy, nonscarring hair loss with variable treatment responses, reflecting unmet clinical needs. Advances in genetic research are improving understanding, yet current treatments often lead to persistent relapses.
January 2024 in “Clinical, cosmetic and investigational dermatology” This review suggests that dermatological cosmetic procedures can be safely performed on dark-complexioned skin with appropriate treatment adjustments, highlighting the need for careful consideration to prevent adverse effects.
January 2024 in “Wiadomości Lekarskie” This presentation explored recent developments in treating alcohol, opioid, and cannabis addiction, highlighting promising pharmacological and behavioral therapies, such as extended-release naltrexone for alcohol use and long-acting buprenorphine for opioids, alongside emerging strategies for cannabis use disorder.
January 2024 in “International journal of advanced biochemistry research” This study observed eight dogs with severe itching, hair loss, and skin lesions that had not responded to previous treatments. After treating the dogs with fluralaner, antibiotics, immune boosters, and omega supplements, partial recovery was seen in one month, with full recovery in two months.